VRDN Stock Summary and Trading Ideas (Viridian Therapeutics | NASDAQ:VRDN)

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.

What symbol and exchange does Viridian Therapeutics shares trade?

Viridian Therapeutics trades on the NASDAQ stock market under the symbol VRDN.

What is Viridian Therapeutics stock price doing today?

As of August 14, 2026, VRDN stock price climbed to $22.08 with 1,007,611 million shares trading.

What is Viridian Therapeutics's Beta?

VRDN has a beta of 0.03, meaning it tends to be less sensitive to market movements. VRDN has a correlation of 0.00 to the broad based SPY ETF.

How much is Viridian Therapeutics worth?

VRDN has a market cap of $2.50 billion. This is considered a Mid Cap stock.

How much money does Viridian Therapeutics make?

Last quarter Viridian Therapeutics reported $233,000 in Revenue and -$1.05 earnings per share. This beat revenue expectation by $211,000 and missed earnings estimates by -$.03.

What is the highest and lowest price Viridian Therapeutics traded in the last 3 year period?

In the last 3 years, VRDN traded as high as $34.29 and as low as $9.90.

What are the top ETFs holding Viridian Therapeutics?

The top ETF exchange traded funds that VRDN belongs to (by Net Assets): XBI, VTI, IWM, VXF, IWN.

Is Viridian Therapeutics (VRDN) a good investment?

VRDN has underperformed the market in the last year with a return of +19.7%, while SPY returned +21.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in VRDN shares. However, VRDN has outperformed the market in the last 3 month and 2 week periods, returning +26.7% and +16.7%, while SPY returned +4.0% and +3.9%, respectively. This indicates VRDN has been having a stronger performance recently.

What are the support and resistance levels for Viridian Therapeutics (VRDN)?

VRDN support price is $21.26 and resistance is $22.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VRDN shares will trade within this expected range on the day.